TNF-αgene 1031 T/C polymorphism in Turkish patients with Behçet's disease

Authors:

Abstract
Background Genetic factors that predispose individuals to Behçet's disease (BD) are considered to play an important role in development of the disease. The tumour necrosis factor (TNF)-α gene, which is closely linked to the HLA-B51 gene, is involved in susceptibility for BD. Recently, a polymorphism at position −1031 within the TNF-α promoter region was demonstrated to be responsible for susceptibility to BD in a British population. However, the functional effects of this polymorphism have not yet been determined. Objectives To investigate the possible relation of the TNF-α–1031 T/C polymorphism with susceptibility to BD in a Turkish population and to determine the functional importance of this polymorphism. Methods Ninety-nine unrelated patients (47 women, 52 men; mean ± SD age, 34·10 ± 10·53 years) with BD and 103 ethnically matched healthy controls (52 males, 51 females; mean ± SD age, 40·25 ± 14·15) were enrolled in the study. For genotyping, polymerase chain reaction – restriction fragment length polymorphism (PCR-RFLP) analysis was employed. The functional importance of TNF-α–1031 T/C polymorphism was determined with an enzyme-linked immunospot (ELISPOT) assay. For this purpose, mononuclear cells obtained from BD patients and controls were analysed for TNF-α and interferon (IFN)-γ production. Results A significant difference was observed between BD patients and controls with respect to the allele frequency of TNF-α–1031C [P = 0·018, OR = 1·83, 95% confidence interval (CI) = 1·07–3·13]. When the allele frequencies were analysed according to the clinical features, the T allele in patients with positive skin pathergy test (SPT) was significantly increased when compared with those of patients without these findings (P = 0·004, OR = 2·75, 95% CI = 1·3–5·86). To demonstrate the frequency of TNF-α and IFN-γ producing cells, mononuclear cells from four representative individuals of each genotype were used and the spontaneous and stimulated TNF-α and IFN-γ values (spot numbers) were analysed. Compared with the control groups, a significant increase was observed in the number of cells producing TNF-α obtained from BD patients (P < 0·001). Moreover, the stimulation index for TNF-α [bacterial lipopolysaccharide (LPS) stimulated/unstimulated] was higher for the CC genotype (9 ± 9·5) with respect to the other genotypes (TT; 1·3 ± 0·3 and TC; 1·2 ± 0·2). While the difference in the spontaneous IFN-γ values between groups were not statistically significant, the stimulated IFN-γ values were found to be significantly increased in the BD group when compared with the healthy control group (P = 0·004). Conclusions Our results showed that, in the Turkish population the TNF-α–1031C allele is associated with susceptibility to BD. On the other hand, carrying the T allele may render patients more prone to developing a positive skin pathergy test. In addition, ELISPOT assays revealed that BD patients exhibited a significantly higher number of mononuclear cells producing TNF-α, and cells obtained from patients with a CC genotype had a stronger response to LPS stimulation. The strong IFN-γ response upon LPS stimulation in BD patients supports the previous findings that BD is a Th1 driven disease. These findings suggest that the TNF-α–1031 polymorphism may have a functional effect and could explain the reason for high levels of TNF-α production observed in BD patients.

This publication has 30 references indexed in Scilit: